Gender and Drug Use Discrimination Among People Who Inject Drugs: An Intersectional Approach Using the COSINUS Cohort.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Applied Bio Materials Pub Date : 2024-03-12 eCollection Date: 2024-01-01 DOI:10.2147/IJWH.S448147
Ilhame Anwar, Aissatou Faye, Jessica Pereira Gonçalves, Laélia Briand Madrid, Gwenaëlle Maradan, Laurence Lalanne, Marie Jauffret-Roustide, Marc Auriacombe, Perrine Roux
{"title":"Gender and Drug Use Discrimination Among People Who Inject Drugs: An Intersectional Approach Using the COSINUS Cohort.","authors":"Ilhame Anwar, Aissatou Faye, Jessica Pereira Gonçalves, Laélia Briand Madrid, Gwenaëlle Maradan, Laurence Lalanne, Marie Jauffret-Roustide, Marc Auriacombe, Perrine Roux","doi":"10.2147/IJWH.S448147","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Injection drug use is strongly associated with stigmatization by loved ones, healthcare providers, and society in general. This stigmatization can have negative consequences on the health of people who inject drugs (PWID) and limit their access to care. Women who inject drugs face greater stigma than men because of gendered social norms and the intersectional effect between gender and drug use identities. For this analysis, we aimed to study discrimination - which is closely linked to stigmatization - experienced by PWID, considering the intersectionality between drug use discrimination and gender discrimination in the French context.</p><p><strong>Methods: </strong>We used data from the COSINUS cohort study, conducted between June 2016 and May 2019 in four French cities. We selected 427 of the 665 PWID who regularly injected drugs enrolled in COSINUS, at three months of follow-up, and performed multivariable logistic regression to identify factors associated with self-reported drug use discrimination.</p><p><strong>Results: </strong>Women comprised 20.6% of the study sample. Sixty-nine percent of the participants declared drug use discrimination and 15% gender discrimination. In the multivariable regression analysis, PWID who had hurried injection out of fear of being seen were almost twice as likely to have experienced drug use discrimination (OR [95% CI]: 1.77 [1.15, 2.74], p = 0.010). Likewise, women experiencing gender discrimination were almost three times as likely to have experienced drug use discrimination (OR [95% CI]: 2.84 [1.07,7.56], p=0.037).</p><p><strong>Conclusion: </strong>Women who inject drugs experienced gender and drug use intersectional discrimination. This could be a reason for the low attendance rates of women in healthcare settings. In addition, discrimination negatively impacted injection drug use practices (eg, hurried injection), particularly for people with unstable housing who injected in public spaces. We recommend introducing adapted services in healthcare facilities for women who inject drugs, and creating a favorable social and physical environment for all PWID in order to improve their health and access to care.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":"16 ","pages":"451-462"},"PeriodicalIF":4.6000,"publicationDate":"2024-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10944247/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IJWH.S448147","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Injection drug use is strongly associated with stigmatization by loved ones, healthcare providers, and society in general. This stigmatization can have negative consequences on the health of people who inject drugs (PWID) and limit their access to care. Women who inject drugs face greater stigma than men because of gendered social norms and the intersectional effect between gender and drug use identities. For this analysis, we aimed to study discrimination - which is closely linked to stigmatization - experienced by PWID, considering the intersectionality between drug use discrimination and gender discrimination in the French context.

Methods: We used data from the COSINUS cohort study, conducted between June 2016 and May 2019 in four French cities. We selected 427 of the 665 PWID who regularly injected drugs enrolled in COSINUS, at three months of follow-up, and performed multivariable logistic regression to identify factors associated with self-reported drug use discrimination.

Results: Women comprised 20.6% of the study sample. Sixty-nine percent of the participants declared drug use discrimination and 15% gender discrimination. In the multivariable regression analysis, PWID who had hurried injection out of fear of being seen were almost twice as likely to have experienced drug use discrimination (OR [95% CI]: 1.77 [1.15, 2.74], p = 0.010). Likewise, women experiencing gender discrimination were almost three times as likely to have experienced drug use discrimination (OR [95% CI]: 2.84 [1.07,7.56], p=0.037).

Conclusion: Women who inject drugs experienced gender and drug use intersectional discrimination. This could be a reason for the low attendance rates of women in healthcare settings. In addition, discrimination negatively impacted injection drug use practices (eg, hurried injection), particularly for people with unstable housing who injected in public spaces. We recommend introducing adapted services in healthcare facilities for women who inject drugs, and creating a favorable social and physical environment for all PWID in order to improve their health and access to care.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
注射吸毒者中的性别与吸毒歧视:使用 COSINUS 群体的交叉方法。
目的:注射吸毒与亲人、医疗服务提供者和整个社会的鄙视密切相关。这种鄙视会对注射吸毒者(PWID)的健康造成负面影响,并限制他们获得医疗服务。由于性别社会规范以及性别与吸毒身份之间的交叉效应,注射吸毒的女性比男性面临更大的污名化。在这项分析中,我们旨在研究注射吸毒者所遭受的歧视(与污名化密切相关),同时考虑到法国背景下吸毒歧视与性别歧视之间的交叉性:我们使用了 2016 年 6 月至 2019 年 5 月期间在法国四个城市开展的 COSINUS 队列研究的数据。我们从参加 COSINUS 的 665 名经常注射毒品的吸毒者中选取了 427 人,进行了三个月的随访,并进行了多变量逻辑回归,以确定与自我报告的吸毒歧视相关的因素:女性占研究样本的 20.6%。69%的参与者宣称受到吸毒歧视,15%的参与者宣称受到性别歧视。在多变量回归分析中,因害怕被发现而匆忙注射的吸毒者遭受吸毒歧视的可能性几乎是其他吸毒者的两倍(OR [95% CI]:1.77 [1.15, 2.74],p = 0.010)。同样,遭受性别歧视的女性遭受吸毒歧视的可能性几乎是其他女性的三倍(OR [95% CI]:2.84 [1.07,7.56],p=0.037):结论:注射毒品的女性遭受过性别和毒品使用方面的交叉歧视。这可能是女性在医疗机构就诊率低的一个原因。此外,歧视还对注射毒品的使用方式(如匆忙注射)产生了负面影响,尤其是对住房不稳定、在公共场所注射毒品的人而言。我们建议在医疗机构中为注射吸毒的女性提供相应的服务,并为所有注射吸毒者创造良好的社会和物质环境,以改善他们的健康状况和获得医疗服务的机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
期刊最新文献
A Systematic Review of Sleep Disturbance in Idiopathic Intracranial Hypertension. Advancing Patient Education in Idiopathic Intracranial Hypertension: The Promise of Large Language Models. Anti-Myelin-Associated Glycoprotein Neuropathy: Recent Developments. Approach to Managing the Initial Presentation of Multiple Sclerosis: A Worldwide Practice Survey. Association Between LACE+ Index Risk Category and 90-Day Mortality After Stroke.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1